| Literature DB >> 36119666 |
Fabio La Porta1, Giada Lullini1, Serena Caselli2, Franco Valzania3, Chiara Mussi2, Claudio Tedeschi3, Giulio Pioli3, Massimo Bondavalli3, Marco Bertolotti2, Federico Banchelli2,4, Roberto D'Amico2,4, Roberto Vicini2,4, Silvia Puglisi2, Pierina Viviana Clerici2, Lorenzo Chiari5,6.
Abstract
Background: Fall risk in the elderly is a major public health issue due to the injury-related consequences and the risk of associated long-term disability. However, delivering preventive interventions in usual clinical practice still represents a challenge. Aim: To evaluate the efficacy of a multiple-component combined with a multifactorial personalized intervention in reducing fall rates in a mixed population of community-dwelling elderly compared to usual care. Design: Randomized Controlled Trial (NCT03592420, clinicalTrials.gov). Setting: Outpatients in two Italian centers. Population: 403 community-dwelling elderly at moderate-to-high fall risk, including subjects with Parkinson's Disease and stroke.Entities:
Keywords: Parkinson's Disease; accidental falls; frail elderly; independent living; primary prevention; randomized controlled trial; rehabilitation; stroke
Year: 2022 PMID: 36119666 PMCID: PMC9475118 DOI: 10.3389/fneur.2022.943918
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Figure 1Study summary flow chart.
AAE and OAE enrolment algorithms.
|
|
|
|---|---|
| FROP-Com Screen | |
| • the absence of at least one inclusion criteria OR | • Total score 0-1: low risk (eligible coefficient = 0) |
| • Total score 12-15: medium risk (eligible coefficient = 1) | |
| • a FRAT ( | |
|
| |
| • the ability to walk 10 meters without assistance AND |
Clinical and demographic sample characteristics.
|
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|
|
| n | (%) | 403 | (100%) | 200 | (49.6%) | 203 | (50.3%) | - |
|
| |||||||||
| Modena | n | (%) | 198 | (49.1%) | 98 | (49.0%) | 100 | (49.3%) | - |
| Reggio Emilia | n | (%) | 205 | (50.9%) | 102 | (51.0%) | 103 | (50.7%) | - |
|
| Mean | (SD) | 76.2 | (6.3) | 76.1 | (6.2) | 76.3 | (6.4) | n.s. |
|
| |||||||||
| Females | n | (%) | 264 | (65.5%) | 130 | (65.0%) | 134 | (66.0%) | n.s. |
| Males | n | (%) | 139 | (34.5%) | 70 | (35.0%) | 69 | (34.0%) | n.s. |
|
| Mean | (SD) | 9.0 | (4.6) | 8.7 | (4.6) | 9.3 | (4.6) | n.s. |
|
| |||||||||
| Elderly, age 65-80 | n | (%) | 176 | (43.7%) | 85 | (42.5%) | 91 | (44.8%) | n.s. |
| Elderly, age >80 | n | (%) | 87 | (21.6%) | 46 | (23.0%) | 41 | (20.2%) | n.s. |
| Elderly, Parkinson | n | (%) | 78 | (19.4%) | 39 | (19.5%) | 39 | (19.2%) | n.s. |
| Elderly, Stroke | n | (%) | 62 | (15.4%) | 30 | (15.0%) | 32 | (15.8%) | n.s. |
|
| |||||||||
| Modified H&Y (PD) | Median | (IQR) | 3 | (1) | 2.5 | (2) | 3 | (1.5) | n.s. |
| NIHSS (Stroke) | Median | (IQR) | 2 | (4) | 2 | (5) | 2.5 | (4) | n.s. |
| Modified LE-FMA Par (Stroke) | Median | (IQR) | 31 | (8) | 31 | (6) | 30 | (11) | n.s. |
| Modified LE-FMA No-Par (Stroke) | Median | (IQR) | 34 | (5) | 35 | (3) | 34 | (6) | n.s. |
|
| |||||||||
| Low | n | (%) | 32 | (7.9%) | 15 | (7.5%) | 17 | (8.4%) | n.s. |
| Medium | n | (%) | 146 | (36.2%) | 72 | (36.0%) | 74 | (36.5%) | n.s. |
| High | n | (%) | 225 | (55.8%) | 113 | (56.5%) | 112 | (55.2%) | n.s. |
sd, standard deviation; n.s., not significant at 0.05 level; H&Y, Modified Hoehn and Yahr scale; Modified LE-FMA Par, ‘Part A: Ability to perform active movements – Lower Extremity' of the modified version of the Fugl-Meyer Motor Assessment (paretic side); Modified LE-FMA No-Par, ‘Part A: Ability to perform active movements – Lower Extremity' of the modified version of the Fugl-Meyer Motor Assessment (non-paretic side); NIHSS, National Institutes of Health Stroke Scale.
Figure 2CONSORT 2010 flow diagram.
Endpoint evaluation between groups (IG and CG).
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|
|
| n | (%) | 403 | - | 200 | 203 | - | ||
| 0 falls | n | (%) | 167 | (41.4%) | 83 | (41.5%) | 84 | (41.4%) | n.s. |
| ≥1 falls | n | (%) | 236 | (58.6%) | 117 | (58.5%) | 119 | (58.6%) | n.s. |
| One fall | n | (%) | 88 | (21.8%) | 40 | (20.0%) | 48 | (23.6%) | n.s. |
| Two falls | n | (%) | 59 | (14.6%) | 26 | (13.0%) | 33 | (16.3%) | n.s. |
| More than two falls (multiple fallers) | n | (%) | 89 | (22.1%) | 51 | (25.5%) | 38 | (18.7%) | n.s. |
| No fallers (0-1 falls) | n | (%) | 255 | (63.3%) | 123 | (61.5%) | 132 | (65.0%) | n.s. |
| Fallers (≥2 falls) | n | (%) | 148 | (36.7%) | 77 | (38.5%) | 71 | (35.0%) | n.s. |
|
| |||||||||
| Total number of falls | n | (%) | 690 | - | 353 | (51.2%) | 337 | (48.8%) | n.s. |
| Mean number of falls per participant | Mean | (SD) | 1.71 | (3.33) | 1.77 | (3.17) | 1.66 | (3.49) | n.s. |
|
| |||||||||
| No injury | n | (%) | 465 | (67.4%) | 238 | (67.4%) | 227 | (67.4%) | n.s. |
| Minor injury, no medical consultation | n | (%) | 106 | (15.4%) | 57 | (16.2%) | 49 | (14.5%) | n.s. |
| Minor injury, with medical consultation | n | (%) | 75 | (10.9%) | 34 | (9.6%) | 41 | (12.2%) | n.s. |
| Serious injury | n | (%) | 44 | (6.4%) | 24 | (6.8%) | 20 | (5.9%) | n.s. |
|
| |||||||||
| Time to the first fall in months | Median | (95%CI) | 11.1 | (9.4–12.3) | 11.1 | (7.6–12.3) | 11.2 | (9.7–NA) | n.s. |
| at 3 months | % | (95%CI) | 77.6% | (73.7–81.8%) | 76.5% | (70.8–82.6%) | 78.8% | (73.4–84.6%) | n.s. |
| at 6 months | % | (95%CI) | 65.0% | (60.5–69.8%) | 63.4% | (57.0–70.4%) | 66.5% | (60.3–73.3%) | n.s. |
| at 12 months | % | (95%CI) | 47.3% | (42.6–52.4%) | 46.8% | (40.3–54.2%) | 47.8% | (41.4–55.2%) | n.s. |
sd, standard deviation; CI95%, confidence interval at 95% level; NA, not applicable; n.s., not significant at 0.05 level.
Multivariate analyses for the final endpoint prediction on the whole sample.
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
| |||||
| Experimental groups | |||||
| Control | - | - | - | - | - |
| Treatment | IRR | 0.94 | 0.71 | 1.25 | 0.676 |
| Risk classes | |||||
| Age 65–80 | - | - | - | - | - |
| Age >80 | IRR | 1.10 | 0.75 | 1.60 | 0.639 |
| Parkinson | IRR | 2.18 | 1.47 | 3.23 | 0.000 |
| Stroke | IRR | 0.66 | 0.41 | 1.04 | 0.076 |
| Gender | |||||
| Female | - | - | - | - | |
| Male | IRR | 1.74 | 1.27 | 2.40 | 0.001 |
|
| |||||
| Experimental groups | |||||
| Control | - | - | - | - | |
| Treatment | OR | 0.88 | 0.59 | 1.32 | 0.536 |
| Risk classes | |||||
| Age 65–80 | - | - | - | - | |
| Age >80 | OR | 1.30 | 0.77 | 2.19 | 0.330 |
| Parkinson | OR | 2.35 | 1.28 | 4.35 | 0.006 |
| Stroke | OR | 0.54 | 0.29 | 0.99 | 0.047 |
| Gender | |||||
| Female | - | - | - | - | |
| Male | OR | 0.87 | 0.55 | 1.39 | 0.570 |
|
| |||||
| Experimental groups | |||||
| Control | - | - | - | - | |
| Treatment | OR | 0.84 | 0.55 | 1.29 | 0.437 |
| Risk classes | |||||
| Age 65–80 | - | - | - | - | |
| Age >80 | OR | 1.72 | 0.99 | 3.00 | 0.054 |
| Parkinson | OR | 3.46 | 1.90 | 6.29 | 0.000 |
| Stroke | OR | 0.99 | 0.50 | 1.97 | 0.983 |
| Gender | |||||
| Female | - | - | - | - | |
| Male | OR | 1.16 | 0.72 | 1.87 | 0.549 |
|
| |||||
| Experimental groups | |||||
| Control | - | - | - | - | |
| Treatment | OR | 0.59 | 0.35 | 1.00 | 0.052 |
| Risk classes | |||||
| Age 65–80 | - | - | - | - | |
| Age >80 | OR | 1.79 | 0.91 | 3.53 | 0.091 |
| Parkinson | OR | 4.14 | 2.11 | 8.11 | 0.000 |
| Stroke | OR | 0.48 | 0.17 | 1.35 | 0.162 |
| Gender | |||||
| Female | - | - | - | - | |
| Male | OR | 1.73 | 0.98 | 3.04 | 0.058 |
|
| |||||
| Experimental groups | |||||
| Control | - | - | - | - | - |
| Treatment | HR | 0.88 | 0.68 | 1.15 | 0.370 |
| Risk classes | |||||
| Age 65–80 | - | - | - | - | - |
| Age >80 | HR | 0.88 | 0.84 | 1.66 | 0.326 |
| Parkinson | HR | 1.18 | 1.21 | 2.48 | 0.003 |
| Stroke | HR | 0.65 | 0.41 | 1.04 | 0.072 |
| Gender | |||||
| Female | - | - | - | - | - |
| Male | HR | 0.93 | 0.68 | 1.26 | 0.619 |
CI95%, Confidence Interval at 95% level; IRR, Incidence Rate Ratio; OR, Odds Ratio; HR, Hazard Ratio.
Each line constitutes an independent variable in the multivariate model for predicting each specific endpoint on the whole sample. The first line of each considered macro variable group (i.e., Control for Experimental groups, Age 65-80 for Risk classes, and Female for Gender) represents the reference category with which the comparison was made.
Figure 3Fall number distribution by group. The intervention group is represented by the red bars and the control group by the blue bars.
Analysis of observed differences between IG and CG.
|
|
|
|
|
| |
|---|---|---|---|---|---|
| Number of falls | IRR | 0.94 | 0.69 | 1.29 | 0.693 |
| Fall probability (1 fall) | RR | 0.94 | 0.79 | 1.12 | 0.503 |
| Multi fall probability (≥2 falls) | RR | 0.89 | 0.67 | 1.17 | 0.398 |
| Multi fall probability (≥3 falls) | RR | 0.68 | 0.45 | 1.01 | 0.052 |
| Time to the first fall | HR | 0.89 | 0.69 | 1.16 | 0.398 |
CI95%, Confidence Interval at 95% level; IRR, Incidence Rate Ratio; RR, Relative Risk; HR, Hazard Ratio.
The association measures are expressed as a comparison between the intervention and control groups.
Analysis of observed differences between subgroups in the IG and CG.
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
| |||||
| Risk classes | |||||
| Age 65–80 | IRR | 0.79 | 0.50 | 1.25 | 0.313 |
| Age >80 | IRR | 0.85 | 0.51 | 1.40 | 0.519 |
| Parkinson | IRR | 0.94 | 0.52 | 1.72 | 0.849 |
| Stroke | IRR | 2.39 | 0.88 | 6.49 | 0.086 |
| Gender | |||||
| Female | IRR | 0.73 | 0.53 | 1.02 | 0.063 |
| Male | IRR | 1.20 | 0.68 | 2.13 | 0.530 |
|
| |||||
| Risk classes | |||||
| Age 65–80 | RR | 0.86 | 0.65 | 1.13 | 0.276 |
| Age >80 | RR | 1.03 | 0.74 | 1.47 | 0.829 |
| Parkinson | RR | 0.93 | 0.70 | 1.23 | 0.615 |
| Stroke | RR | 1.22 | 0.63 | 2.35 | 0.553 |
| Gender | |||||
| Female | RR | 0.89 | 0.72 | 1.11 | 0.307 |
| Male | RR | 1.04 | 0.77 | 1.40 | 0.791 |
|
| |||||
| Risk classes | |||||
| Age 65–80 | RR | 0.72 | 0.33 | 1.55 | 0.397 |
| Age >80 | RR | 0.52 | 0.22 | 1.24 | 0.125 |
| Parkinson | RR | 0.62 | 0.36 | 1.05 | 0.068 |
| Stroke | RR | 3.75 | 0.44 | 31.7 | 0.185 |
| Gender | |||||
| Female | RR | 0.83 | 0.58 | 1.21 | 0.334 |
| Male | RR | 0.98 | 0.65 | 1.48 | 0.917 |
|
| |||||
| Risk classes | |||||
| Age 65–80 | RR | 0.85 | 0.51 | 1.42 | 0.542 |
| Age >80 | RR | 1.21 | 0.65 | 1.95 | 0.682 |
| Parkinson | RR | 0.72 | 0.48 | 1.19 | 0.111 |
| Stroke | RR | 1.21 | 0.51 | 2.83 | 0.667 |
| Gender | |||||
| Female | RR | 0.56 | 0.31 | 1.00 | 0.048 |
| Male | RR | 0.83 | 0.49 | 1.41 | 0.487 |
|
| |||||
| Risk classes | |||||
| Age 65–80 | HR | 0.83 | 0.56 | 1.25 | 0.381 |
| Age >80 | HR | 0.92 | 0.54 | 1.59 | 0.776 |
| Parkinson | HR | 0.83 | 0.49 | 1.41 | 0.497 |
| Stroke | HR | 1.32 | 0.58 | 3.01 | 0.509 |
| Gender | |||||
| Female | HR | 0.82 | 0.59 | 1.13 | 0.216 |
| Male | HR | 1.03 | 0.66 | 0.61 | 0.895 |
CI95%, Confidence Interval at 95% level; IRR, Incidence Rate Ratio; RR, Relative Risk; HR, Hazard Ratio.
The association measures are expressed as a comparison between the subgroups in the IG and CG.
Rasch analysis results (final analyses) on scales used for pre-test vs. post-test differences analysis.
|
|
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
| ||
| FROP-Com | Final analysis | −0.322 | 1.557 | −0.483 | 0.810 | 26.16036 | 0.509 | −0.660 | 0.555 | 0,711 | - |
| Balance scales | Final analysis | 1.260 | 4.697 | 0.418 | 0.991 | 42.64727 | 1.202 | 1.045 | 1.169 | 0,962 | - |
|
|
|
|
|
|
|
|
| ||||
|
| |||||||||||
FROP-Com, Fall Risk for Older People living in the Community; SD, standard deviation; df, degrees of freedom; P, Bonferroni-corrected p-value; PSI, person separation index; α, Cronbach's alpha.
Analysis of pre-test vs. post-test differences for FROP-Com and balance indicators.
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| ||
| FROP-Com | Pre | −0.5 | 0.5 | 200 | −0.5 | 0.5 | 203 | |||
| Post | −0.9 | 0.6 | 132 | −0.9 | 0.6 | 153 | ||||
| Post–pre | −0.3 | 0.4 | 132 | −0.3 | 0.4 | 153 | −0.03 (−0.13; 0.07) | 0.543 | −0.08 (−0.32; 0.15) | |
| BBS | Pre | 2.2 | 1.6 | 200 | 2.1 | 1.6 | 203 | |||
| Post | 2.5 | 1.8 | 156 | 2.6 | 1.8 | 184 | ||||
| Post –pre | 0.1 | 2.7 | 156 | 0.5 | 2.3 | 184 | 0.15 (−0.23; 0.53) | 0.445 | 0.14 (−0.08; 0.35) | |
| POMA | Pre | 2.6 | 1.8 | 200 | 2.6 | 1.9 | 203 | |||
| Post | 3.0 | 1.9 | 156 | 3.1 | 1.9 | 182 | ||||
| Post–pre | 0.2 | 1.2 | 156 | 0.3 | 1.3 | 182 | 0.12 (−0.14; 0.37) | 0.363 | 0.10 (−0.11; 0.31) | |
| MBT | Pre | 0.6 | 2.3 | 198 | 0.4 | 2.4 | 200 | |||
| Post | 1.0 | 2.5 | 156 | 1.2 | 2.7 | 182 | ||||
| Post-pre | 0.2 | 1.8 | 155 | 0.6 | 2.0 | 179 |
|
|
| |
| FABS | Pre | 0.4 | 1.2 | 200 | 0.4 | 1.2 | 203 | |||
| Post | 0.4 | 1.2 | 156 | 0.4 | 1.3 | 184 | ||||
| Post-pre | 0.1 | 0.7 | 156 | 0.3 | 0.7 | 184 |
|
|
| |
sd, standard deviation; MD, mean differences in post-test values adjusted for pre-test values; CI95%, Confidence Interval at 95% level; FROP-Com, Fall Risk for Older People in the Community; BBS, Berg Balance Scale; POMA, Performance Oriented Mobility Assessment; FABS, Fullerton Advanced Balance Scale; MBT, Mini-BESTest.
In bold, significant pre-test vs. post-test differences were reported.